Statistics for Cosmo Pharmaceuticals N.V. (id:13088 COPN)
Valuation metrics
Market cap
1.01B
Enterprise value
824.63M
Trailing P/E (ttm)
15.56
Forward P/E
11.30
PEG ratio
11.30
Price/Sales (ttm)
5.43
Price/Book (mrq)
2.02
Enterprise Value/Revenue
4.75
Enterprise Value/EBITDA
8.82
Overview
Shares outstanding
16.05M
Float
8.42M
Shares short
% Held by insiders
0.47%
% Held by institutions
0.12%
Average volume (10 days)
13.10K
Average volume (90 days)
Price summary
52-Week low
38.20
52-Week high
80.60
52-Week change
38.72%
Beta
1.29
50-Day moving average
72.78
200-Day moving average
71.49
Dividends and splits
Forward annual dividend rate
8.00
Forward annual dividend yield
0.13
Trailing annual dividend rate
2.00%
Trailing annual dividend yield
0.03
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
July 12th, 2024
Ex-dividend date
July 10th, 2024
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
37.54%
Operating margin
63.83%
Operational effectiveness
Return on assets
7.82%
Return on equity
14.80%
Income statement
Revenue (ttm)
11.52
Revenue per share (ttm)
11.52
Quarterly revenue growth (yoy)
50.14
Gross profit (ttm)
73.94M
EBITDA
24.02M
Net income to common (ttm)
65.12M
Diluted EPS (ttm)
4.03
Quarterly earnings growth (yoy)
5.01K%
Balance sheet
Total cash (mrq)
124.87M
Total cash per share (mrq)
8.32
Total debt (mrq)
1.36M
Total Debt/Equity (mrq)
0.29
Current ratio (mrq)
484.70%
Book value per share (mrq)
31.06
Cash flow
Cash flow statement
109.81M
Levered free cash flow (LFCF)
68.19M